LARSON MATTHEW PAUL 4
4 · Slide Insurance Holdings, Inc. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
Slide Insurance (SLDE) CRO Matthew Larson Exercises Options, Sells Shares
What Happened
- Matthew Paul Larson, Chief Risk Officer of Slide Insurance Holdings (SLDE), exercised vested stock options and sold shares on March 16, 2026. He sold 11,250 shares in an open-market transaction at $18.00 per share, generating $202,500 in proceeds. The filing shows an exercise/acquisition of 11,250 shares at a $0.79 strike price (cost $8,888) and a separate derivative conversion/disposing entry for 11,250 shares at $0.00 (no cash proceeds).
- This activity reflects an option exercise plus an immediate sale of a portion of the shares; sales are generally routine (liquidity/tax) rather than a direct bullish purchase signal.
Key Details
- Transaction date: 2026-03-16; Sale price: $18.00; Sale proceeds: $202,500.
- Exercise details: 11,250 shares exercised at $0.79 (total ~$8,888). Filing also shows a 11,250-share derivative conversion/disposition at $0.00 (no proceeds).
- Footnotes: F1 — exercised and sold pursuant to a 10b5-1 trading plan adopted Dec 4, 2025; F2 — the stock options were fully vested and exercisable.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Filing timeliness: filed 2026-03-17 for 2026-03-16 transactions (filed promptly).
Context
- This was an option exercise with an immediate sale of shares under a pre-established 10b5-1 plan. The 10b5-1 plan indicates the sale was pre-scheduled and helps insulate the trading from questions about contemporaneous insider knowledge; it does not itself indicate the insider’s view of the company’s prospects.
- For retail investors: purchases or exercises that are followed by sales are often for liquidity or tax reasons. The key takeaway here is a routine exercise-and-sell by a corporate officer, not a revealed long-term accumulation.
Insider Transaction Report
Form 4
LARSON MATTHEW PAUL
Chief Risk Officer
Transactions
- Exercise/Conversion
Common Stock
2026-03-16$0.79/sh+11,250$8,888→ 11,250 total - Sale
Common Stock
[F1]2026-03-16$18.00/sh−11,250$202,500→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F2]2026-03-16−11,250→ 65,000 totalExercise: $0.79Exp: 2032-02-21→ Common Stock (11,250 underlying)
Footnotes (2)
- [F1]Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025.
- [F2]These stock options are fully vested and exercisable.
Signature
/s/ Anastasios Omiridis, Attorney-in-Fact for Matthew Larson|2026-03-17